{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:24Z","timestamp":1786120344286,"version":"build-2736575974"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1097\/cad.0b013e32834a0c8e","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T18:32:56Z","timestamp":1317753176000},"page":"32-42","source":"Crossref","is-referenced-by-count":35,"title":["Antitumor effects of the benzophenanthridine alkaloid sanguinarine in a rat syngeneic model of colorectal cancer"],"prefix":"10.1097","volume":"23","author":[{"given":"Francesca","family":"Pica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalucia","family":"Serafino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziana","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Garaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Sinibaldi-Vallebona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210203","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002.","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"R2-4-20210203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0029-1242465","article-title":"Overview of systemic therapy for colorectal cancer.","volume":"22","author":"Goodwin","year":"2009","journal-title":"Clin Colon Rectal Surg"},{"key":"R3-4-20210203","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Multicenter International Study of Oxaliplatin5-FluorouracilLeucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) investigators oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.","volume":"350","author":"Andre","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-4-20210203","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.2174\/0929867013372094","article-title":"Advances in cancer therapy with plant based natural products.","volume":"8","author":"Mukherjee","year":"2001","journal-title":"Curr Med Chem"},{"key":"R5-4-20210203","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/15287398709530972","article-title":"Short-term toxicity studies of sanguinarine and of two alkaloid extracts of Sanguinaria canadensis L.","volume":"20","author":"Becci","year":"1987","journal-title":"J Toxicol Environ Health"},{"key":"R6-4-20210203","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(79)90245-0","article-title":"Sanguinarine: a positive inotropic alkaloid which inhibits cardiac Na, K-ATPase.","volume":"60","author":"Seifen","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"R7-4-20210203","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/0731-7085(91)80048-E","article-title":"Characterization of Sanguinaria canadensis L. fluid extract by FAB mass spectrometry.","volume":"9","author":"Bambagiotti-Alberti","year":"1991","journal-title":"J Pharm Biomed Anal"},{"key":"R8-4-20210203","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-2007-971493","article-title":"Anti-inflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus.","volume":"43","author":"Lenfeld","year":"1981","journal-title":"Planta Med"},{"key":"R9-4-20210203","first-page":"145","article-title":"Antimicrobial agents from higher plants. An investigation of Hunnemannia fumariaefolia pseudoalcoholates of sanguinarine and chelerythrine.","volume":"41","author":"Mitscher","year":"1978","journal-title":"Lloydia"},{"key":"R10-4-20210203","doi-asserted-by":"crossref","first-page":"30129","DOI":"10.1074\/jbc.272.48.30129","article-title":"Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappa B activation, I kappa B alpha fosforilation, and degradation.","volume":"272","author":"Chaturvedi","year":"1997","journal-title":"J Biol Chem"},{"key":"R11-4-20210203","first-page":"1524","article-title":"Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells.","volume":"6","author":"Ahmad","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R12-4-20210203","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1158\/1535-7163.933.3.8","article-title":"Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery.","volume":"3","author":"Adhami","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"R13-4-20210203","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0006-2952(02)00902-4","article-title":"The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death.","volume":"63","author":"Ding","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"R14-4-20210203","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1158\/0008-5472.CAN-05-4033","article-title":"Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity.","volume":"66","author":"Huh","year":"2006","journal-title":"Cancer Res"},{"key":"R15-4-20210203","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1111\/j.1742-4658.2006.05227.x","article-title":"The benzophenanthridine alkaloid sanguinarine perturbes microtubule assembly dynamics through tubulin binding. A possible mechanism for its antiproliferative activity.","volume":"273","author":"Lopus","year":"2006","journal-title":"FEBS J"},{"key":"R16-4-20210203","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s00280-003-0609-9","article-title":"Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion.","volume":"51","author":"Debiton","year":"2003","journal-title":"Cancer Chemother Pharmacol"},{"key":"R17-4-20210203","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2121-7-13","article-title":"Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine.","volume":"7","author":"Holy","year":"2006","journal-title":"BMC Cell Biol"},{"key":"R18-4-20210203","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/0008-5472.CAN-06-3764","article-title":"Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells.","volume":"67","author":"Hussain","year":"2007","journal-title":"Cancer Res"},{"key":"R19-4-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.canlet.2005.05.037","article-title":"Apoptotic response of uveal melanoma cells upon treatment with chelidonine, sanguinarine and chelerythrine.","volume":"237","author":"Kemeny-Beke","year":"2006","journal-title":"Cancer Lett"},{"key":"R20-4-20210203","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.bcp.2009.07.011","article-title":"Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.","volume":"78","author":"De Stefano","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"R21-4-20210203","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cbi.2007.12.006","article-title":"Sanguinarine causes DNA damage and p53-independent cell death in human colon cancer cell lines.","volume":"172","author":"Matkar","year":"2008","journal-title":"Chem Biol Interact"},{"key":"R22-4-20210203","first-page":"4457","article-title":"Sanguinarine sensitizes human gastric adenocarcinoma AGS cells to TRAIL-mediated apoptosis via down-regulation of AKT and activation of caspase-3.","volume":"29","author":"Choi","year":"2009","journal-title":"Anticancer Res"},{"key":"R23-4-20210203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.canlet.2006.08.018","article-title":"Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulation in Bcl-2 family proteins.","volume":"249","author":"Ahsan","year":"2007","journal-title":"Cancer Lett"},{"key":"R24-4-20210203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tiv.2008.12.013","article-title":"Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion.","volume":"23","author":"Jang","year":"2009","journal-title":"Toxicol in Vitro"},{"key":"R25-4-20210203","first-page":"149","article-title":"The cytotoxic agents NSC-95397, brefeldin A, bortezomib and sanguinarine induce apoptosis in neuroendocrine tumors.","volume":"30","author":"Larsson","year":"2010","journal-title":"Anticancer Res"},{"key":"R26-4-20210203","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbrc.2010.07.114","article-title":"Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways.","volume":"399","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R27-4-20210203","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/CAD.0b013e328117f463","article-title":"Induction of apoptosis by sanguinarine in C6 rat glioblastoma cells is associated with the modulation of the Bcl-2 family and activation of caspases through downregulation of extracellular signal-regulated kinase and Akt.","volume":"18","author":"Han","year":"2007","journal-title":"Anticancer Drugs"},{"key":"R28-4-20210203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jpba.2009.09.014","article-title":"Metabolism of sanguinarine in human and in rat: characterization of oxidative metabolites produced by human CYP1A1 and CYP1A2 and rat liver microsomes using liquid chromatography-tandem mass spectrometry.","volume":"52","author":"Deroussent","year":"2010","journal-title":"J Pharm Biomed Anal"},{"key":"R29-4-20210203","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1751-1097.2007.00156.x","article-title":"Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer.","volume":"83","author":"Ahsan","year":"2007","journal-title":"Photochem Photobiol"},{"key":"R30-4-20210203","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fct.2004.09.005","article-title":"In vivo DNA damaging potential of sanguinarine alkaloid, isolated from argemone oil, using alkaline Comet assay in mice.","volume":"43","author":"Ansari","year":"2005","journal-title":"Food Chem Toxicol"},{"key":"R31-4-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5507\/bp.2008.005","article-title":"Macleaya cordata extract and Sangrovit genotoxicity. Assessment in vivo.","volume":"152","author":"Stiborova","year":"2008","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"R32-4-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.mrgentox.2004.06.004","article-title":"Sanguinarine: an evaluation of in vivo cytogenetic activity.","volume":"563","author":"Das","year":"2004","journal-title":"Mutat Res"},{"key":"R33-4-20210203","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/rtph.1999.1339","article-title":"Viadent usage and oral leukoplakia: a spurious association.","volume":"30","author":"Munro","year":"1999","journal-title":"Regul Toxicol Pharmacol"},{"key":"R34-4-20210203","first-page":"115","article-title":"Effectiveness of chemical products as antiplaque agents.","volume":"3","author":"Lopez Lozano","year":"1991","journal-title":"Rev Eur Odontoestomatol"},{"key":"R35-4-20210203","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/ijc.2910320517","article-title":"Selection by trypsin of two sublines of rat colon cancer cells forming progressive or aggressive tumors.","volume":"32","author":"Martin","year":"1983","journal-title":"Int J Cancer"},{"key":"R36-4-20210203","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0002-9440(10)65351-5","article-title":"Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.","volume":"154","author":"Guadagni","year":"1999","journal-title":"Am J Pathol"},{"key":"R37-4-20210203","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<540::AID-IJC16>3.0.CO;2-V","article-title":"A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells.","volume":"85","author":"Rasi","year":"2000","journal-title":"Int J Cancer"},{"key":"R38-4-20210203","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/ijc.2910570516","article-title":"Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.","volume":"57","author":"Rasi","year":"1994","journal-title":"Int J Cancer"},{"key":"R39-4-20210203","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/ijc.20063","article-title":"Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats.","volume":"110","author":"Sinibaldi-Vallebona","year":"2004","journal-title":"Int J Cancer"},{"key":"R40-4-20210203","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0168-1702(01)00285-4","article-title":"Efficacy of 3-azido 3deoxythymidine (AZT) in preventing HTLV-1 transmission to human cord blood mononuclear cells.","volume":"78","author":"Zhang","year":"2001","journal-title":"Virus Res"},{"key":"R41-4-20210203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cellbi.2007.09.004","article-title":"Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells.","volume":"32","author":"Kaminskyy","year":"2008","journal-title":"Cell Biol Int"},{"key":"R42-4-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10565-006-0109-x","article-title":"The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.","volume":"22","author":"Malikova","year":"2006","journal-title":"Cell Biol Toxicol"},{"key":"R43-4-20210203","first-page":"3176","article-title":"Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes.","volume":"9","author":"Adhami","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R44-4-20210203","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/jcb.21672","article-title":"Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL.","volume":"104","author":"Kim","year":"2008","journal-title":"J Cell Biochem"},{"key":"R45-4-20210203","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2004.03.077","article-title":"Suppression of angiogenesis by the plant alkaloid, sanguinarine.","volume":"317","author":"Eun","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R46-4-20210203","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/10408449709089896","article-title":"Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil.","volume":"27","author":"Das","year":"1997","journal-title":"Crit Rev Toxicol"},{"key":"R47-4-20210203","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/jat.1360","article-title":"Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration.","volume":"28","author":"Choy","year":"2008","journal-title":"J Appl Toxicol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32834a0c8e","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:22Z","timestamp":1786047862000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-201201000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32834a0c8e","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}